Last edition
News about "US FDA cGMP Inspection"
Cipla's InvaGen Facility Gets Zero US FDA Form 483 Observations
Cipla’s InvaGen facility has received zero Form 483 observations from the US FDA following an inspection.
US FDA CGMP Inspection | 27/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members